In this interview, Dr. John Bishop discusses the scientific and regulatory challenges of NAM adoption, where companies should ...

With the April 2005 release of its Little Dipper Microarray Processing System, Sunnyvale, Calif.-based SciGene has now completed its benchtop system for automated microarray processing from ...

Micron Biomedical will be among the select honorees featured in the print edition of Fast Company on newsstands beginning March 31, 2026.

Get our Editor-in-Chief Michelle Itano's BioTechniques Q1 2026 highlights, featuring an optimized Southern blot protocol and ...

Alongside the rebrand, Terrestrial is planning to establish a new headquarters and manufacturing facility in Boston.

Built from thickets of glucose, galactose, mannose and more, the glycome plays key roles in cell communication, immunity and ...

This year’s most innovative smaller companies prove that head count doesn’t cap ambition. These Small and Mighty standouts (51 to 200 employees) are thinking well beyond their ...

Hi and welcome to our monthly video series called what’s trending online. At the HCP site there are six articles that readers ...

A large meta-analysis of over 20,000 people found that modern genetic testing can identify a clinically meaningful cause of schizoprenia in about 1 in 16 patients (6%), especially in early-onset ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs ...

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, enabling timely medical guidance and informed decision-making.